GSK Crisis Aftermath In China Hits Sales Representatives
This article was originally published in PharmAsia News
Executive Summary
A number of GSK China’s pharmaceutical sales representatives are using social media to complain that bonuses for the fourth quarter in 2013 were suspended or denied and that the motivation to meet sales targets has waned sharply as a result.